D. Wagner (Lund, Sweden), V. Ho (London, United Kingdom)
New physiomimetic model for ARDS in vitro studies
E. Marhuenda (Barcelona (Catalonia), Spain), A. Villarino (Barcelona (Catalonia), Spain), M. Narciso (Barcelona (Catalonia), Spain), N. Gavara (Barcelona (Catalonia), Spain), R. Farre (Barcelona (Catalonia), Spain), I. Almendros (Barcelona (Catalonia), Spain), J. Otero (Barcelona (Catalonia), Spain)
|  |
Establishment of a human in-vitro model for airway epithelial repair and regeneration
A. Chakraborty (Munich, Germany), M. Mastalerz (Munich, Germany), R. Hatz (Munich, Germany), J. Behr (Munich, Germany), M. Lindner (Munich, Germany), A. Hilgendorff (Munich, Germany), C. Staab-Weijnitz (Munich, Germany)
|  |
Divergent effects of macrophage migration inhibitory factor and D-dopachrome tautomerase on lung epithelial regeneration
S. Song (Groningue (GR), Netherlands), H. Habibie (Groningue (GR), Netherlands), M. Jager (Groningue (GR), Netherlands), C. Brandsma (Groningue (GR), Netherlands), G. Poelarends (Groningue (GR), Netherlands), B. Melgert (Groningue (GR), Netherlands)
| |
Culturing primary alveolar epithelial cells on lung hydrogels preserves the type II phenotype
E. Marhuenda (Barcelona, Spain), A. Villarino (Barcelona, Spain), M. Narciso (Barcelona, Spain), N. Gavara (Barcelona, Spain), R. Farré (Barcelona, Spain), I. Almendros (Barcelona, Spain), J. Otero (Barcelona, Spain)
| |
Collagen hydrogels reinforced with bacterial nanocellulose fibers for the development of in vitro 3D lung models
N. Malandain (Barcelona, Spain), H. Sanz-Fraile (Barcelona, Spain), R. Farré (Barcelona, Spain), A. Laromaine (Barcelona, Spain), A. Roig (Barcelona, Spain), J. Otero (Barcelona, Spain)
| |
Murine Precision Cut Lung Slices as a model of heme-induced acute injury.
N. Kewalramani (Bern, Switzerland), C. Machahua (Bern, Switzerland), B. Fabian (Bern, Switzerland), M. Scalice (Bern, Switzerland), J. Petracca (Bern, Switzerland), M. Schorer (Bern, Switzerland), F. Kaesermann (Bern, Switzerland), K. Fytianos (Bern, Switzerland), M. Funke-Chambour (Bern, Switzerland)
| |
Ex vivo modeling of human lung fibrogenesis and drug mode of action screens using single cell RNA-seq in precision-cut lung slices
N. Lang (München, Germany), M. Ansari (München, Germany), L. Yang (München, Germany), S. Zhou (München, Germany), D. Porras-Gonzalez (München, Germany), A. Agami (München, Germany), C. Mayr (München, Germany), B. Hooshiar Kashani (München, Germany), L. Heumos (München, Germany), M. Gerckens (München, Germany), Y. Chen (München, Germany), J. Schniering (München, Germany), M. Stoleriu (Gauting, Germany), R. Hatz (Gauting, Germany), J. Behr (München, Germany), F. Theis (München, Germany), G. Burgstaller (München, Germany), H. Schiller (München, Germany)
| |
LSC - 2022 - Ex vivo modelling of human lung fibrogenesis and drug mode of action screens using single-cell RNA-seq in precision-cut lung slices
N. Lang (Munich, Germany), M. Ansari (Munich, Germany), D. Porras-Gonzalez (Munich, Germany), A. Agami (Munich, Germany), B. Hooshiar Kashani (Munich, Germany), S. Zhou (Munich, Germany), L. Yang (Munich, Germany), M. Gerckens (Munich, Germany), X. Wei (Munich, Germany), C. Mayr (Munich, Germany), J. Schniering (Munich, Germany), M. Stoleriu (Munich-Gauting, Gauting, Germany), R. Hatz (Munich-Gauting, Gauting, Germany), J. Behr (Munich, Germany), G. Burgstaller (Munich, Germany), H. Schiller (Munich, Germany)
| |
A tunable lung physiomimetic stretch system evaluated with precision cut lungs slices and recellularized human lung scaffold>
O. Rosmark (Lund, Sweden), A. Ibáñez Fonseca (Lund, Sweden), J. Thorsson (Lund, Sweden), G. Dellgren (Gothenburg, Sweden), O. Hallgren (Lund, Sweden), A. Larsson Callerfelt (Lund, Sweden), L. Elowsson (Lund, Sweden), G. Westergren-Thorsson (Lund, Sweden)
| |
Pulmonary endothelial cells support growth of human alveolar organoids: possible influence of cigarette smoke exposure
A. Ravi (Leiden, Netherlands), X. Wu (Groningen, Netherlands), A. M. Van Der Does (Leiden, Netherlands), A. Van Der Meer (Enschede, Netherlands), J. M. Johnson (Birmingham, Netherlands), M. C. Harmsen (Groningen, Netherlands), R. Gosens (Groningen, Netherlands), P. S. Hiemstra (Leiden, Netherlands)
| |
Using forward genetic screens and novel human alveolar organoid models to study surfactant protein C trafficking in heath and disease
E. Rutherford (Cambridge, United Kingdom), D. Van Den Boomen (Cambridge, United Kingdom), K. Lim (Cambridge, United Kingdom), P. Lehner (Cambridge, United Kingdom), E. Rawlins (Cambridge, United Kingdom), S. Marciniak (Cambridge, United Kingdom), J. Dickens (Cambridge, United Kingdom)
| |
Heterogeneity of airway remodeling in cystic fibrosis
A. Vermaut (Leuven, Belgium), V. Geudens (Leuven, Belgium), L. Willems (Leuven, Belgium), J. Kaes (Leuven, Belgium), H. Beeckmans (Leuven, Belgium), C. De Fays (Brussel, Belgium), L. Ceulemans (Leuven, Belgium), R. Vos (Leuven, Belgium), B. Vanaudenaerde (Leuven, Belgium), L. Dupont (Leuven, Belgium), M. Boon (Leuven, Belgium)
| |
Antimicrobial-induced changes in the intestinal microflora affected hydrogen gas production in a mouse model of acute lung injury
M. Kawano (Sagamihara Kanagawa, Japan), K. Kobayashi (Sagamihara Kanagawa, Japan), K. Kokubo (Sagamihara Kanagawa, Japan), M. Kubota (Sagamihara Kanagawa, Japan)
| |
Methotrexate induces DIILD sporadically and at low incidence in rodents, similar to clinical scenario in humans
N. Fransén Pettersson (Lund, Sweden), C. Carvalho (Lund, Sweden), I. Mahmutovic Persson (Lund, Sweden), H. Falk-Håkansson (Lund, Sweden), J. Liu (Lund, Sweden), L. Olsson (Malmö, Sweden), K. Von Wachenfeldt (Lund, Sweden)
| |
Acute exacerbation in chronic pulmonary fibrosis: Histopathological and molecular characterisation of the mice model
C. Yegen (Bobigny, France), L. Haine (Bobigny, France), D. Marchant (Bobigny, France), C. Planes (Bobigny, France), N. Voituron (Bobigny, France), E. Boncoeur (Bobigny, France)
| |
Moderate and severe hyperoxia in preterm rabbits: airway reactivity, forced expiration and forced oscillation outcomes
Y. Regin (Leuven, Belgium), A. Gie (Leuven, Belgium), I. Valenzuela (Leuven, Belgium), M. Greyling (Leuven, Belgium), V. Lenders (Leuven, Belgium), J. Vanoirbeek (Leuven, Belgium), J. Toelen (Leuven, Belgium)
| |
Late Breaking Abstract - Idiopathic pulmonary fibrosis-on-chip: A new model based on biological membranes
P. Zamprogno (Bern, Switzerland), J. Schulte (Bern, Switzerland), T. Weber (Bern, Switzerland), A. Sengupta (Bern, Switzerland), T. Geiser (Bern, Switzerland), O. Guenat (Bern, Switzerland)
| |
Late Breaking Abstract - Spatially resolved transcriptomics of human and mouse fibrotic lung
L. Franzén (Stockholm, Sweden), M. Olsson Lindvall (Gothenburg, Sweden), S. Jackson (Gothenburg, Sweden), G. Hamm (Cambridge, United Kingdom), B. Keith (Gothenburg, Sweden), S. Oag (Gothenburg, Sweden), A. Collin (Gothenburg, Sweden), J. Cann (Gaithersburg, United States), J. Lindgren (Gothenburg, Sweden), G. Belfield (Gothenburg, Sweden), A. Ollerstam (Gothenburg, Sweden), M. Stamou (Gothenburg, Sweden), P. Ståhl (Stockholm, Sweden), J. Hornberg (Gothenburg, Sweden)
| |
Late Breaking Abstract - Febuxostat inhibits inflammation and fibrosis in a murine model of LPS-induced lung injury
S. Ohta (Tokyo, Japan), H. Ikeda (Tokyo, Japan), T. Ebato (Tokyo, Japan), H. Inoue (Tokyo, Japan), T. Homma (Tokyo, Japan), S. Suzuki (Tokyo, Japan), A. Tanaka (Tokyo, Japan), H. Sagara (Tokyo, Japan)
| |